Phase 3 Readout~month
Phase 3 Topline: A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979
- Drug
- follicular
- Indication
- Follicular Lymphoma (FL)
Other upcoming events for WST
Phase 3 ReadoutPhase 3 Topline: A Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral Osteoarthritis
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Multi-Regional, Phase 3 Study to Evaluate the Efficacy and Safety of AP3
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolum
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolum
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.